SCHEMBL7309416

SCHEMBL7309416

CC(=O)c1ccc2ccccc2c1[O]

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.50
HPGD P15428 3/20 0.50
MAPT P10636 2/20 0.50
WDR5 P61964 1/20 0.50
MAOB P27338 1/20 0.49
LDHA P00338 1/20 0.48
NR4A1 P22736 1/20 0.44
NR4A2 P43354 1/20 0.44
NR4A3 Q92570 1/20 0.44
KDM4E B2RXH2 3/20 0.43
PBRM1 Q86U86 1/20 0.43
MEN1 O00255 1/20 0.43
NSD2 O96028 1/20 0.43
POLB P06746 1/20 0.43
KMT2A Q03164 1/20 0.43
MCL1 Q07820 1/20 0.43
PLK1 P53350 1/20 0.43
HSD17B10 Q99714 2/20 0.42
CYP2A6 P11509 1/20 0.42
TSHR P16473 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL164035 0.82 WDR5 (0.68) ALDH1A1HPGDWDR5LDHANR4A1
SCHEMBL165467 0.80 WDR5 (0.50) ALDH1A1HPGDMAPTWDR5LDHA
SCHEMBL9618656 0.80 TSHR (0.52) ALDH1A1HPGDMAPTWDR5MAOB
SCHEMBL975681 0.80 NCEH1 (0.53) ALDH1A1HPGDMAPTWDR5MAOB
SCHEMBL29390177 0.80 LDHA (0.69) MAPTWDR5LDHAKDM4EMEN1
SCHEMBL431650 0.80 LDHA (0.69) MAPTWDR5LDHAKDM4EMEN1
SCHEMBL164091 0.79 PLK1 (0.66) ALDH1A1HPGDMAPTWDR5LDHA
SCHEMBL161927 0.79 MAPT (0.52) ALDH1A1HPGDMAPTWDR5LDHA
SCHEMBL163509 0.79 KDM4E (0.48) ALDH1A1HPGDMAPTWDR5LDHA
SCHEMBL2831990 0.78 CYP1A1 (0.55) ALDH1A1HPGDMAPTWDR5MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5629406-A AMINO ACID DERIVATIVES SANKYO COMPANY, LIMITED (JP) 1997-05-13 US disclosed
EP-0587311-A1 Peptides capable of inhibiting the activity of HIV protease, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1994-03-16 EP disclosed